HC Wainwright & Co. Reiterates Buy on Biohaven, Maintains $59 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Biohaven (NYSE:BHVN) and maintained a price target of $59, indicating confidence in the company's future performance.
September 24, 2024 | 10:50 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Biohaven, maintaining a $59 price target. This suggests confidence in Biohaven's future performance and potential stock price appreciation.
The reiteration of a Buy rating and maintenance of a $59 price target by HC Wainwright & Co. indicates a positive outlook on Biohaven's stock. This can lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100